Background: Yearly about 9 million people develop tuberculosis (TB), of which about 1 million cases occur in children less than 15 years. The diagnosis of tuberculous disease in children remains a challenge. Children with pulmonary tuberculosis are mostly unable to produce sputum therefore gastric aspirates (GA) remain the procedure of choice for microbiologic confirmation of tuberculous disease; however, yield is frequently low.
To evaluate the use of gastric aspirates as the specimen of choice in diagnosis of pulmonary tuberculosis in children of 0-11 years of age in NHLS Free state.
Methods & Materials: Retrospective study was conducted on 508 Gastric aspirates specimens submitted to NHLS from January 2012 to April 2013 from children ≤11 years of age suspected of having pulmonary tuberculosis. Of the 508, (45%) were females while (55%) were males. The laboratory results (direct microscopy and culture) were retrieved from NHLS DISA and reviewed Results: Among the 508 children's gastric aspirates specimen submitted to NHLS for TB diagnosis; six specimens were positive in direct microscopy (Auramin phenol staining) and eight had a positive culture. Only two specimens were both culture and direct microscopy positive. Among the 10 specimen that were positive by culture, eight were drug susceptible while two were multidrug resistant (MDR).
Conclusion: Data presented here indicates that, in this laboratory, Gastric aspirates analysis did not significantly contribute in the laboratory diagnosis of pulmonary tuberculosis in children. Therefore the use of special bicarbonate tube or cup was advised in GA collection. Background: Human African Trypanosomiasis and Neglected tropical diseases (NTDs) are some of the most common conditions affecting people living in sub-Saharan Africa (SSA), and together produce a burden of disease that may be equivalent to up to onehalf of SSA's malaria disease burden and more than double that of tuberculosis (Hotez et.,al 2009) . The diagnosis of these diseases is cumbersome, based on a high index of clinical suspicion. This study entails developing recombinant proteins, determining the sensitivity and specificity of these antigens and evaluating their usability in the determination of sero prevalence of the parasite and disease burden to the community and nation as a whole using multiplex technology.
Methods & Materials: cDNA for Trypanosoma brucei gambiense antigens with tandem repeat were chemically synthesized by Integrated DNA Technologies (IDT), and others were cloned from the genomic DNA. The cDNAs were cloned into pET52b expression vector, then expressed in E.coli BL21(DE3). They were subjected to a His-tag only or His-tag/StrepTagII double affinity purification. The antigens will be coupled onto microsphere beads and used for multiplex analysis.
Results: We have successfully expressed and purified 14 recombinant antigens from inclusion body and soluble proteins; GM6, Tbg6, MARP, FCaBP, 65kDa ISG, 64kDa ISG, RBP29, CBH11803, CHB12270, CBH17169, CBH18122 N terminus, CBH18122 tandem repeat, I 2 , and I 17 . The protein expression was rated as good, ok or low. 78.6% expressed good, 14.3% ok and 7.1% low respectively. 64.3% were expressed from soluble proteins while 35.7% were expressed from inclusion body proteins. 28.6% of the antigens were found in both inclusion bodies and soluble proteins with 75% of these antigens found in inclusion bodies.
Conclusion: Recombinant trypanosome antigens can be used for human and zoonotic trypanosome disease surveillance. However, for practical development, pathogens and antigens of interest must be selected and optimized. When optimized, the multiplex technology will contribute to surveillance of trypanosome infections. Optimization of the purified antigens is now in progress to determine the sensitivity and specificity of the recombinant antigens. Highly specific and sensitive antigens will then be set for surveillance program.
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